Cargando…
Personalized Medicine in Coronary Artery Disease: Where Are We in 2022?
Autores principales: | Shchekochikhin, Dmitry, Kopylov, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502540/ https://www.ncbi.nlm.nih.gov/pubmed/36143231 http://dx.doi.org/10.3390/jpm12091446 |
Ejemplares similares
-
Coronary Artery Bypass Grafting in Acute Ischemic Heart Failure:
Where do We Stand? (And Where Should We Go?)
por: Kubrusly, Fernando B., et al.
Publicado: (2018) -
From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We?
por: Tondo, Giacomo, et al.
Publicado: (2022) -
Alzheimer’s disease and infections, where we stand and where we go
por: Monastero, Roberto, et al.
Publicado: (2014) -
Managing Malignant Pleural Mesothelioma in the Age of Personalized Medicine: Where Are We and What Is Still Missing?
por: Stella, Giulia Maria, et al.
Publicado: (2022) -
Personalized and Precision Medicine 2022
por: Caminade, Anne-Marie
Publicado: (2023)